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Monday, February 4, 2013 203aGdþ3 and GsMTx-4 are more effective than BTP2 or over-expression of a dom-
inant negative Orai1 (E190Q) in decreasing [Ca2þ]i in MH-RyR1
R163C myo-
tubes suggesting that it is mediated by an alternative non-Stim1/Orai1 entry
pathway. Exposure to a DAG analog induced a larger increase in Ca2þ in
MH-RyR1R163C myotubes than in WT cells and was completely blocked by
Gd3þ and GsMTx-4 suggesting that TRPC3/6 could be involved. Further sup-
port is that these non-selective cationic channels are over-expressed and that
[Na]i is elevated in MHRyR1
R163C cells. In vivo in MH-RyR1R163C/Wt muscle
intracellular Ca2þ and Naþ overload can be blocked by dantrolene, and
attenuated by Gd3þ and GsMTx-4. Exposure of MH-RyR1R163C/Wt mice to
halothane markedly increased both [Ca2þ]i and [Na
þ]i in their muscle fibers.
These effects of halothane were markedly attenuated by Gdþ3 or GsMTx-4
and completely suppressed by dantrolene. Taken together these results strongly
suggest that sarcolemmal Ca2þ and Naþ entry via TRPC3/6 are important con-
tributors to the altered Ca2þ and Naþ homeostasis observed in MHmuscle both
at rest and during an MH crisis.
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Central Core Disease is a myopathy resulting generally from a mutation in the
RYR1 gene, encoding the skeletal muscle calcium release channel RyR1. No
treatment is currently available for this disease. We studied a pathological
situation in which an affected child harbors two recessive mutations, resulting
in a massive reduction in the RyR1 amount. The paternal mutation inducing the
inclusion of a new in frame exon in the mRNA of RyR1, resulted in the inser-
tion of additional amino-acids and destabilization of the protein. We hypothe-
sized that inducing the skipping of this exon would be sufficient to restore
RyR1 expression and normalization of calcium releases. We developed U7-
AON lentiviral vectors to induce exon-skipping on affected primary muscle
cells. The efficiency of the exon skipping at the mRNA level, at the protein
level and at the functional level using calcium imaging were evaluated. We
observed in these affected primary muscle culture a reduction in the inclusion
of the additional exon, an increase in the RyR1 protein expression, and a resto-
ration of normal calcium releases. This study is the first demonstration of the
potential of exon skipping for the therapy of Central Core Disease, from the
molecular to the functional level.
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Contractile dysfunction of atria and atrial arrhythmias are common comorbid-
ities in heart failure (HF). Although abnormal Ca handling has been recognized
to underlie both reduced contractility and increased propensity to arrhythmias
in failing left ventricle, its role in HF-related atrial pathogenesis is not well es-
tablished. We studied Ca handling in control and HF myocytes isolated from
left atrial appendage using canine model of chronic heart failure. In this model,
chronic HF was associated with reduced left atrial contractility, increased in-
ducibility of atrial fibrillation, and shortened atrial action potential. Amplitude
of Ca transients and cellular shortening was significantly reduced in field-
stimulated myocytes from HF compared to control group. Diminished Ca tran-
sients recorded in voltage-clamped HF myocytes were associated with reduced
amplitude of the L-type Ca currents and decreased gain of excitation-
contraction coupling. HF myocytes displayed spatial segregation of Ca signal-
ing manifested in impaired propagation of Ca transient from surface to the
center. Frequency of Ca sparks in permeabilzed myocytes was higher in HF,
while sarcoplasmic reticulum (SR) Ca content was similar in both control
and HF groups. Despite of the increased functional activity of ryanodine recep-
tors, rate of occurrence of diastolic Ca waves and corresponding delayed after
depolarizations recorded in paced intact myocytes in a presence of beta-
adrenergic receptor agonist isoproterenol was significantly lower in HF than
in controls. We conclude that reduced atrial contractility observed in canine
model of chronic HF can be attributed, at least in part, to the decreased efficacy
of Ca current to trigger SR Ca release. Furthermore, our cellular data do not
support Ca-dependent triggered activity in left atrial appendage as a mechanism
for atrial arrhythmia in chronic HF.1041-Plat
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T tubule remodeling is one of the prevalent characteristics of failing heart. The
structural protein Bin1 has been reported to be involved in t-tubule formation.
The interaction of exon10 domain of Bin1 with phosphatidylinositol-4,5-
bisphosphate [PIP2] appears to be crucial for localization of Bin1 to t-tubules.
Molecular basis for t-tubule disruption during transition from hypertrophy to
heart failure (HF) has not been identified yet. We hypothesized that PLCb1-
induced hydrolysis of PIP2 reduces the targeting of Bin1 to t-tubules and leads
to t-tubule disruption. Through co-localization experiments in normal rat ven-
tricular myocardium, we found that Bin1, PIP2 and PLCb1 were all located in
t-tubules. Next, we focused our attention on the importance of Bin1 for t-tubule
formation by overexpression of Bin1 in HL1 cells. These HL1 cells normally
do not have t-tubules and lack Bin1. After 24 hours of Bin1 overexpression,
cells showed tubular structures that were absent in control (empty vector) cells.
We also found that these tubular structures were continuous with plasma
membrane like normal t-tubules in ventricular myocytes. To further understand
the mechanism of t-tubules loss, Bin1 overexpressed cells were treated with
200nM endothelin1 (Et1). Et1 significantly increased the activity of PLCb1.
After 48 hours, Et1 treated HL1 cells start showing tubule degeneration and sig-
nificantly fewer cells with tubules compared to the non-treatment cells. Overall
our data indicate that Bin1, PIP2 and PLCb1 may form a signaling complex at
t-tubules and that hydrolysis of PIP2 through PLCb1 might be crucial for
t-tubule degeneration during HF progression. In addition, the HL1 cell line
can be a useful experimental model especially for cardiac studies of t-tubule
formation and remodeling in disease.
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Junctin is an integral membrane protein of the sarcoplasmic reticulum (SR)
encoded by the Aspartyl beta-hydroxylase (AbH) gene. The AbH gene can un-
dergo different alternative splicing events, generating at least three distinct pro-
teins, the Aspartyl beta-hydroxylase, junctin and junctate, all sharing the same
transmembrane domain and a short highly charged acidic luminal region, but
carrying distinct intraluminal tails. Interstingly, junctin and junctate are both
expressed in skeletal muscle, but only junctin was shown to interact and co-
localize with the Ca2þ release complex in the junctional SR, whereas junctate
displays a typical longitudinal SR distribution. These two proteins may thus
represent an ideal molecular model to investigate the presence of specific re-
gions responsible for protein targeting to the junctional SR.
To this aim, junctin deletion mutants were tagged with a green fluorescent pro-
tein (GFP) and expressed in primary myoblasts. The results obtained showed
that even deletion of small regions within intraluminal domain of junctin re-
sulted in protein mislocalization, thus indicating that the entire luminal se-
quence is required for protein targeting to the junctional SR. Interestingly,
the same region, if inserted downstream the cytoplasmic and trasmembrane
domains of sarcolipin, a resident protein of the longitudinal SR, is able to
completely re-localize the protein to the junctional SR, further confirming
that the intraluminal domain of junctin may actually contain minimal junctional
SR targeting sequences.
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Ca2þ homeostasis primarily involves two major morphological subdivisions of
the sarcoplasmic reticulum (SR): junctional (jSR) cisterna that appose sarco-
lemma, and free (fSR) tubules surrounding myofilaments. Biochemical isola-
tion of jSR and fSR membranes involves selective increases in density of SR
membrane vesicles using the SR Ca2þ pump (SERCA2a) (Jones and Cala, J.
Biol. Chem. 1981). The purpose of the current study was to comprehensively
characterize cardiac SR subproteomes. Purified SR membranes were solubi-
lized, trypsinized and analyzed by LC-MS/MS on a LTQ-XL mass spectrome-
ter. Abundant species were fragmented with collision-induced dissociation
(CID). Data analysis was performed using Proteome Discoverer 1.1 (Thermo)
which incorporated the Mascot algorithm (Matrix Science). In replicate
